Previous postdocs and students from the Arginine Methylation Laboratory
Moving on to new pastures, but still very much missed
Dr Agnieszka Zielinska
After completing her post-doc in the Davies Lab working on the identification of novel PRMT1 substrates in breast cancer and developing state-of-the-art in vivo mouse techniques, Agnieszka is now working as a technical manager at the University of Birmingham.
Dr Pilar Sanchez-Bailon
Pilar identified the deubiquitylating enzyme, USP11, as a new PRMT1 substrate and has characterised a role for methyl-USP11 in the repair of double strand breaks by homologous recombination. She is now completing a second post-doc in the Max-Delbrück-Center for Molecular Medicine (MDC), Berlin, Germany.
After completing his PhD in the Davies Lab understanding how PRMT5 regulates homologous-recombination-mediated DSB repair, Tom was awarded an EMBO Long-Term Fellowship to join the lab of Dr Johnathan Whetstine (MGH, Harvard) to work on lysine demethylases and aberrant copy number gains in cancer. He is now working in the lab of Dr Raul Mostoslavsky, (MGH, Harvard) investigating acetylation and the DNA damage response.
Dr James Jarrold
After completing a PhD using quantitative proteomics to understand how PRMT1 functions in breast cancer, James is now working as a post-doc at Warwick University.
Kerianne, having completed her MRes on bio-orthogonal profiling for PRMTs, is now working as a marketing analyst at Calibre Scientific Inc.
Zac is at the lab of Dr. Cristine Schmidt, University of Manchester completing a PhD studying ubquitin-like modifiers in the DNA damage response.
James Van Hear
Lisa is now completing a PhD in Munich, Germany.
Jimmy, is conducting a PhD at UCL, London, working on wound healing in cancer organoids.
Sophie is now at the University of Birmingham clinical trials department.
Wendy is a PhD student at the University of Birmingham on the BBSRC MIBTP doctoral training programme.
Summik is now a PhD student at Imperial College, London.